{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T03:18:07Z","timestamp":1778987887215,"version":"3.51.4"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Lambert Initiative for Cannabinoid Therapeutics","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"The Lambert Initiative for Cannabinoid Therapeutics","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"The Lambert Initiative for Cannabinoid Therapeutics","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"The Lambert Initiative for Cannabinoid Therapeutics","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"The Lambert Initiative for Cannabinoid Therapeutics","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"The Lambert Initiative for Cannabinoid Therapeutics","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"The Lambert Initiative for Cannabinoid Therapeutics","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-84897-w","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T10:02:12Z","timestamp":1738663332000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["An analysis of the cultivation, consumption and composition of home-grown cannabis following decriminalisation in the Australian Capital Territory"],"prefix":"10.1038","volume":"15","author":[{"given":"Cilla","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isobel","family":"Lavender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"McCartney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard C.","family":"Kevin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Bedoya-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iain S.","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"key":"84897_CR1","unstructured":"Department of Health and Aged Care - Australian Government. Narcotic Drugs Amendment Act 2016 (2016)."},{"key":"84897_CR2","doi-asserted-by":"publisher","unstructured":"Macphail, S. L. et al. Medicinal cannabis prescribing in Australia: an analysis of trends over the first five years. Front. Pharmacol. 13 https:\/\/doi.org\/10.3389\/fphar.2022.885655 (2022).","DOI":"10.3389\/fphar.2022.885655"},{"key":"84897_CR3","unstructured":"Therapeutic Goods Administration. Medicinal cannabis Special Access Scheme B data. (2024)."},{"key":"84897_CR4","doi-asserted-by":"crossref","unstructured":"Mills, L. et al. Medical cannabis use in Australia Seven Years after Legalisation: Findings from the Online Cannabis as Medicine Survey 2022 (CAMS-22) (Research Square Platform LLC [preprint], 2024).","DOI":"10.21203\/rs.3.rs-3912730\/v1"},{"key":"84897_CR5","doi-asserted-by":"publisher","unstructured":"Lintzeris, N. et al. Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20). Harm Reduct. J. 19 https:\/\/doi.org\/10.1186\/s12954-022-00666-w (2022).","DOI":"10.1186\/s12954-022-00666-w"},{"key":"84897_CR6","doi-asserted-by":"publisher","first-page":"103307","DOI":"10.1016\/j.drugpo.2021.103307","volume":"97","author":"D Perkins","year":"2021","unstructured":"Perkins, D. et al. Medicinal cannabis and driving: the intersection of health and road safety policy. Int. J. Drug Policy. 97, 103307. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103307 (2021).","journal-title":"Int. J. Drug Policy"},{"key":"84897_CR7","unstructured":"Australian Bureau of Statistics. Region summary: Australian Capital Territory.  https:\/\/www.abs.gov.au\/statistics\/people\/people-and-communities\/socio-economic-indexes-areas-seifa-australia\/2021 (2021)."},{"key":"84897_CR8","unstructured":"Hughes, C., Shanahan, M., Ritter, A., McDonald, D. & Gray-Weale, F. Evaluation of the Australian Capital Territory Drug Diversion Programs (Drug Policy Modelling Program National Drug and Alcohol Research Centre, The University of New South Wales, 2013)."},{"key":"84897_CR9","unstructured":"ACT Parliamentary Council. Drugs of Dependence Act 1989. Report No. A1989-11. (2023)."},{"key":"84897_CR10","unstructured":"Australian Capital Territory Legislative Assembly. Inquiry into Drugs of Dependence (Personal Cannabis Use) Amendment Bill 2018. (2019)."},{"key":"84897_CR11","unstructured":"Australian Criminal Intelligence Commission. Illicit Drug Data Report (Australian Criminal Intelligence Commission, 2023)."},{"key":"84897_CR12","unstructured":"Australian Institute of Health and Welfare. National Drug Strategy Household Survey 2022-23 (AIHW, 2024)."},{"key":"84897_CR13","unstructured":"Australian Institute of Health and Welfare. Alcohol, tobacco & other drugs in Australia. https:\/\/www.aihw.gov.au\/reports\/alcohol\/alcohol-tobacco-other-drugs-australia (2023)."},{"key":"84897_CR14","unstructured":"Sutherland, R. et al. National Drug and Alcohol Research Centre, UNSW Sydney, Sydney,. Australian Drug Trends 2022: Key Findings from the National Ecstasy and Related Drugs Reporting System (EDRS) Interviews. (2022)."},{"key":"84897_CR15","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1111\/dar.13518","volume":"41","author":"L Barrett","year":"2022","unstructured":"Barrett, L., Mellor, R., Ritter, A., McLauchlan, L. & Kearnes, M. Navigating the grey: experiences of incremental cannabis reform in Australia. Drug Alcohol Rev. 41, 1621\u20131629. https:\/\/doi.org\/10.1111\/dar.13518 (2022).","journal-title":"Drug Alcohol Rev."},{"key":"84897_CR16","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1111\/bcp.13695","volume":"84","author":"LM Dryburgh","year":"2018","unstructured":"Dryburgh, L. M. et al. Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects. Br. J. Clin. Pharmacol. 84, 2468\u20132476. https:\/\/doi.org\/10.1111\/bcp.13695 (2018).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"84897_CR17","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1111\/j.1360-0443.2008.02230.x","volume":"103","author":"J McLaren","year":"2008","unstructured":"McLaren, J., Swift, W., Dillon, P. & Allsop, S. Cannabis potency and contamination: a review of the literature. Addiction 103, 1100\u20131109. https:\/\/doi.org\/10.1111\/j.1360-0443.2008.02230.x (2008).","journal-title":"Addiction"},{"key":"84897_CR18","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.drugalcdep.2018.07.040","volume":"192","author":"S Lenton","year":"2018","unstructured":"Lenton, S., Frank, V. A., Barratt, M. J., Potter, G. R. & Decorte, T. Growing practices and the use of potentially harmful chemical additives among a sample of small-scale cannabis growers in three countries. Drug Alcohol Depend. 192, 250\u2013256. https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.07.040 (2018).","journal-title":"Drug Alcohol Depend."},{"key":"84897_CR19","doi-asserted-by":"publisher","unstructured":"Lenton, S. et al. Growing practices and the use of potentially harmful chemical additives from a web survey of mainly small-scale cannabis growers in 18 countries. Int. J. Drug Policy. 104662 https:\/\/doi.org\/10.1016\/j.drugpo.2024.104662 (2024).","DOI":"10.1016\/j.drugpo.2024.104662"},{"key":"84897_CR20","doi-asserted-by":"crossref","unstructured":"McPartland, J. M. & McKernan, K. J. In In Cannabis sativa L. - Botany and Biotechnology. (eds Chandra, S. et al.) 457\u2013474  (Springer International Publishing, 2017).","DOI":"10.1007\/978-3-319-54564-6_22"},{"key":"84897_CR21","doi-asserted-by":"publisher","unstructured":"Punja, Z. K., Ni, L., Lung, S. & Buirs, L. Total yeast and mold levels in high THC-containing cannabis (Cannabis sativa L.) inflorescences are influenced by genotype, environment, and pre-and post-harvest handling practices. Front. Microbiol. 14 https:\/\/doi.org\/10.3389\/fmicb.2023.1192035 (2023).","DOI":"10.3389\/fmicb.2023.1192035"},{"key":"84897_CR22","unstructured":"Olsen, A. et al. CanTEST Health and Drug Checking Service Program Evaluation: Final Report (The Australian National University, 2023)."},{"key":"84897_CR23","unstructured":"Vyver, J. Calls to expand Canberra\u2019s pill-testing regime to include cannabis grown in backyards. https:\/\/www.abc.net.au\/news\/2022-10-07\/calls-to-examine-cannabis-plant-varieties-used-by-canberrans\/101510920  (2022)."},{"key":"84897_CR24","unstructured":"Vyver, J. Backyard medicinal cannabis crops eyed for university study. https:\/\/youtu.be\/evj7eRhh3m0?si=IxTu80dWlA1PXwI1 (2022)."},{"key":"84897_CR25","doi-asserted-by":"publisher","first-page":"7381","DOI":"10.1007\/s00216-020-02862-8","volume":"412","author":"G McRae","year":"2020","unstructured":"McRae, G. & Melanson, J. E. Quantitative determination and validation of 17 cannabinoids in cannabis and hemp using liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 412, 7381\u20137393. https:\/\/doi.org\/10.1007\/s00216-020-02862-8 (2020).","journal-title":"Anal. Bioanal. Chem."},{"key":"84897_CR26","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1002\/cbdv.200790145","volume":"4","author":"F Taura","year":"2007","unstructured":"Taura, F., Sirikantaramas, S., Shoyama, Y., Shoyama, Y. & Morimoto, S. Phytocannabinoids in Cannabis sativa: recent studies on biosynthetic enzymes. Chem. Biodivers. 4, 1649\u20131663. https:\/\/doi.org\/10.1002\/cbdv.200790145 (2007).","journal-title":"Chem. Biodivers."},{"key":"84897_CR27","doi-asserted-by":"publisher","first-page":"e70052","DOI":"10.1371\/journal.pone.0070052","volume":"8","author":"W Swift","year":"2013","unstructured":"Swift, W., Wong, A., Li, K. M., Arnold, J. C. & McGregor, I. S. Analysis of Cannabis seizures in NSW, Australia: Cannabis potency and cannabinoid profile. PLOS ONE. 8, e70052. https:\/\/doi.org\/10.1371\/journal.pone.0070052 (2013).","journal-title":"PLOS ONE"},{"key":"84897_CR28","doi-asserted-by":"publisher","first-page":"108496","DOI":"10.1016\/j.yebeh.2021.108496","volume":"127","author":"A Suraev","year":"2022","unstructured":"Suraev, A., Benson, M. J., Martin, L., Lintzeris, N. & McGregor, I. S. Determination of contaminants in artisanal cannabis products used for childhood epilepsy in the Australian community: a sub-analysis of the \u2018PELICAN\u2019 study. Epilepsy Behav. 127, 108496. https:\/\/doi.org\/10.1016\/j.yebeh.2021.108496 (2022).","journal-title":"Epilepsy Behav."},{"key":"84897_CR29","unstructured":"Therapeutic Goods Administration. (ed Australian Government Department of Health and Aged Care). Australia, (2017)."},{"key":"84897_CR30","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing. https:\/\/www.R-project.org\/ (2023)."},{"key":"84897_CR31","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham, H. et al. Welcome to the Tidyverse. J. Open. Source Softw. 4, 1686. https:\/\/doi.org\/10.21105\/joss.01686 (2019).","journal-title":"J. Open. Source Softw."},{"key":"84897_CR32","unstructured":"tidyr: Tidy Messy Data v. R package version 1.3.1. (2024)."},{"key":"84897_CR33","unstructured":"Wickham, H., Fran\u00e7ois, R., Henry, L. & M\u00fcller, K. dplyr: a grammar of data manipulation. 2020. R package version 0.8 4 (2021)."},{"key":"84897_CR34","unstructured":"Hmisc Harrell miscellaneous. v. R package version 5.1-1 (2023)."},{"key":"84897_CR35","unstructured":"ggplot2: Elegant Graphics for Data Analysis. New York, (2016)."},{"key":"84897_CR36","unstructured":"Venables, B. & Ripley, B. (2002)."},{"key":"84897_CR37","unstructured":"Fox, J., Weisberg, S. & An, R. Companion to Applied Regression, 3rd ed.  (Sage, 2019)."},{"key":"84897_CR38","unstructured":"Lenth, R. V. emmeans: Estimated Marginal Means, aka Least-Squares Means. R package version 1.10.5-0900003 (2024)."},{"key":"84897_CR39","unstructured":"New Zealand Ministry of Health. Guideline on the Regulation of Medicinal cannabis in New Zealand: Part 3 Guidance for a New Medicinal Cannabis Product Application (Ministry of Health, 2020)."},{"key":"84897_CR40","unstructured":"ACT Government Health. Review of the operation of the Drugs of Dependence (Personal Cannabis Use) Amendment Act 2019. Canberra, ACT, (2024)."},{"key":"84897_CR41","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.drugpo.2014.12.007","volume":"26","author":"GR Potter","year":"2015","unstructured":"Potter, G. R. et al. Global patterns of domestic cannabis cultivation: sample characteristics and patterns of growing across eleven countries. Int. J. Drug Policy. 26, 226\u2013237. https:\/\/doi.org\/10.1016\/j.drugpo.2014.12.007 (2015).","journal-title":"Int. J. Drug Policy"},{"key":"84897_CR42","doi-asserted-by":"publisher","first-page":"100372","DOI":"10.1016\/j.puhip.2023.100372","volume":"5","author":"A Reiman","year":"2023","unstructured":"Reiman, A., Meisel, J. S. & Capler, R. Paulding McCready, D. Medical cannabis identity and public health paternalism. Public. Health Pract. 5, 100372. https:\/\/doi.org\/10.1016\/j.puhip.2023.100372 (2023).","journal-title":"Public. Health Pract."},{"key":"84897_CR43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3109\/09687637.2011.614970","volume":"19","author":"B Fischer","year":"2011","unstructured":"Fischer, B. et al. Characteristics and predictors of health problems from use among high-frequency cannabis users in a Canadian university student population. Drugs: Educ. Prev. Policy. 19, 49\u201358. https:\/\/doi.org\/10.3109\/09687637.2011.614970 (2011).","journal-title":"Drugs: Educ. Prev. Policy"},{"key":"84897_CR44","doi-asserted-by":"publisher","unstructured":"Costiniuk, C. et al. Why a distinct medical stream is necessary to support patients using cannabis for medical purposes. J. Cannabis Res. 5 https:\/\/doi.org\/10.1186\/s42238-023-00195-8 (2023).","DOI":"10.1186\/s42238-023-00195-8"},{"key":"84897_CR45","doi-asserted-by":"publisher","first-page":"104123","DOI":"10.1016\/j.drugpo.2023.104123","volume":"119","author":"GC Dertadian","year":"2023","unstructured":"Dertadian, G. C. Is non-medical use normal? Normalisation, medicalisation and pharmaceutical consumption. Int. J. Drug Policy. 119, 104123. https:\/\/doi.org\/10.1016\/j.drugpo.2023.104123 (2023).","journal-title":"Int. J. Drug Policy"},{"key":"84897_CR46","doi-asserted-by":"publisher","first-page":"108781","DOI":"10.1016\/j.drugalcdep.2021.108781","volume":"225","author":"J Turna","year":"2021","unstructured":"Turna, J. et al. Cannabis use and misuse in the year following recreational cannabis legalization in Canada: a longitudinal observational cohort study of community adults in Ontario. Drug Alcohol Depend. 225, 108781. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108781 (2021).","journal-title":"Drug Alcohol Depend."},{"key":"84897_CR47","doi-asserted-by":"publisher","first-page":"107660","DOI":"10.1016\/j.drugalcdep.2019.107660","volume":"205","author":"BA Reboussin","year":"2019","unstructured":"Reboussin, B. A. et al. Trends in marijuana edible consumption and perceptions of harm in a cohort of young adults. Drug Alcohol Depend. 205, 107660. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107660 (2019).","journal-title":"Drug Alcohol Depend."},{"key":"84897_CR48","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s11606-018-4741-y","volume":"34","author":"SR Yoo","year":"2019","unstructured":"Yoo, S. R. et al. Perceptions of the comparative safety of different forms of Marijuana use among the adult US population. J. Gen. Intern. Med. 34, 504\u2013506. https:\/\/doi.org\/10.1007\/s11606-018-4741-y (2019).","journal-title":"J. Gen. Intern. Med."},{"key":"84897_CR49","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1111\/dar.13444","volume":"41","author":"L Mills","year":"2022","unstructured":"Mills, L., Lintzeris, N., O\u2019Malley, M., Arnold, J. C. & McGregor, I. S. Prevalence and correlates of cannabis use disorder among australians using cannabis products to treat a medical condition. Drug Alcohol Rev. 41, 1095\u20131108. https:\/\/doi.org\/10.1111\/dar.13444 (2022).","journal-title":"Drug Alcohol Rev."},{"key":"84897_CR50","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.drugpo.2012.08.001","volume":"23","author":"E Hammersvik","year":"2012","unstructured":"Hammersvik, E., Sandberg, S. & Pedersen, W. Why small-scale cannabis growers stay small: five mechanisms that prevent small-scale growers from going large scale. Int. J. Drug Policy. 23, 458\u2013464. https:\/\/doi.org\/10.1016\/j.drugpo.2012.08.001 (2012).","journal-title":"Int. J. Drug Policy"},{"key":"84897_CR51","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.drugpo.2014.07.005","volume":"26","author":"P Hakkarainen","year":"2015","unstructured":"Hakkarainen, P. et al. Growing medicine: small-scale cannabis cultivation for medical purposes in six different countries. Int. J. Drug Policy. 26, 250\u2013256. https:\/\/doi.org\/10.1016\/j.drugpo.2014.07.005 (2015).","journal-title":"Int. J. Drug Policy"},{"key":"84897_CR52","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.drugpo.2017.12.004","volume":"53","author":"A Klein","year":"2018","unstructured":"Klein, A. & Potter, G. R. The three betrayals of the medical cannabis growing activist: from multiple victimhood to reconstruction, redemption and activism. Int. J. Drug Policy. 53, 65\u201372. https:\/\/doi.org\/10.1016\/j.drugpo.2017.12.004 (2018).","journal-title":"Int. J. Drug Policy"},{"key":"84897_CR53","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.drugpo.2014.08.002","volume":"26","author":"S Lenton","year":"2015","unstructured":"Lenton, S., Frank, V. A., Barratt, M. J., Dahl, H. V. & Potter, G. R. Attitudes of cannabis growers to regulation of cannabis cultivation under a non-prohibition cannabis model. Int. J. Drug Policy. 26, 257\u2013266. https:\/\/doi.org\/10.1016\/j.drugpo.2014.08.002 (2015).","journal-title":"Int. J. Drug Policy"},{"key":"84897_CR54","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1080\/00952990.2022.2132507","volume":"48","author":"E Wadsworth","year":"2022","unstructured":"Wadsworth, E., Schauer, G. L. & Hammond, D. Home cannabis cultivation in the United States and differences by state-level policy, 2019\u20132020. Am. J. Drug Alcohol Abuse. 48, 701\u2013711. https:\/\/doi.org\/10.1080\/00952990.2022.2132507 (2022).","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"84897_CR55","doi-asserted-by":"publisher","first-page":"100423","DOI":"10.1016\/j.abrep.2022.100423","volume":"15","author":"E Wadsworth","year":"2022","unstructured":"Wadsworth, E., Cristiano, N., Pacheco, K., Jesseman, R. & Hammond, D. Home cultivation across Canadian provinces after cannabis legalization. Addict. Behav. Rep. 15, 100423. https:\/\/doi.org\/10.1016\/j.abrep.2022.100423 (2022).","journal-title":"Addict. Behav. Rep."},{"key":"84897_CR56","doi-asserted-by":"publisher","unstructured":"Sogaard, T. F. et al. Global patterns in small-scale cannabis growers\u2019 distribution practices: Exploring the grower-distributor nexus. Int. J. Drug Policy. 104463 https:\/\/doi.org\/10.1016\/j.drugpo.2024.104463 (2024).","DOI":"10.1016\/j.drugpo.2024.104463"},{"key":"84897_CR57","doi-asserted-by":"publisher","first-page":"e0253387","DOI":"10.1371\/journal.pone.0253387","volume":"16","author":"D Jin","year":"2021","unstructured":"Jin, D., Henry, P., Shan, J. & Chen, J. Classification of cannabis strains in the Canadian market with discriminant analysis of principal components using genome-wide single nucleotide polymorphisms. PLOS ONE. 16, e0253387. https:\/\/doi.org\/10.1371\/journal.pone.0253387 (2021).","journal-title":"PLOS ONE"},{"key":"84897_CR58","doi-asserted-by":"publisher","first-page":"e0267498","DOI":"10.1371\/journal.pone.0267498","volume":"17","author":"CJ Smith","year":"2022","unstructured":"Smith, C. J., Vergara, D., Keegan, B. & Jikomes, N. The phytochemical diversity of commercial Cannabis in the United States. PLOS ONE. 17, e0267498. https:\/\/doi.org\/10.1371\/journal.pone.0267498 (2022).","journal-title":"PLOS ONE"},{"key":"84897_CR59","doi-asserted-by":"publisher","first-page":"111309","DOI":"10.1016\/j.forsciint.2022.111309","volume":"335","author":"VM Carvalho","year":"2022","unstructured":"Carvalho, V. M. et al. Chemical profiling of Cannabis varieties cultivated for medical purposes in southeastern Brazil. Forensic Sci. Int. 335, 111309. https:\/\/doi.org\/10.1016\/j.forsciint.2022.111309 (2022).","journal-title":"Forensic Sci. Int."},{"key":"84897_CR60","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3390\/horticulturae8060531","volume":"8","author":"A Galic","year":"2022","unstructured":"Galic, A. et al. Effects of cold temperature and acclimation on cold tolerance and cannabinoid profiles of Cannabis sativa L. (hemp). Horticulturae 8, 531. https:\/\/doi.org\/10.3390\/horticulturae8060531 (2022).","journal-title":"Horticulturae"},{"key":"84897_CR61","unstructured":"Bureau of Meteorology. Climate of Australian - Major Cities.  http:\/\/www.bom.gov.au\/climate\/australia\/cities\/ (2024)."},{"key":"84897_CR62","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.bpsc.2020.12.016","volume":"6","author":"MA Elsohly","year":"2021","unstructured":"Elsohly, M. A., Chandra, S., Radwan, M., Majumdar, C. G. & Church, J. C. A comprehensive review of cannabis potency in the United States in the last decade. Biol. Psychiatry: Cogn. Neurosci. Neuroimaging. 6, 603\u2013606. https:\/\/doi.org\/10.1016\/j.bpsc.2020.12.016 (2021).","journal-title":"Biol. Psychiatry: Cogn. Neurosci. Neuroimaging"},{"key":"84897_CR63","unstructured":"Therapeutic Goods Administration. Medicinal cannabis products by active ingredients. https:\/\/www.tga.gov.au\/medicinal-cannabis-products-active-ingredients (2023)."},{"key":"84897_CR64","unstructured":"Cannabiz. in Cannabiz Vol. (ed Steve Jones) (Cannabiz, Australia, 2024). (2024)."},{"key":"84897_CR65","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/s2215-0366(19)30048-3","volume":"6","author":"M Di Forti","year":"2019","unstructured":"Di Forti, M. et al. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. Lancet Psychiatry. 6, 427\u2013436. https:\/\/doi.org\/10.1016\/s2215-0366(19)30048-3 (2019).","journal-title":"Lancet Psychiatry"},{"key":"84897_CR66","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1001\/jamapsychiatry.2020.1035","volume":"77","author":"LA Hines","year":"2020","unstructured":"Hines, L. A. et al. Association of high-potency cannabis use with mental health and substance use in adolescence. JAMA Psychiatry. 77, 1044\u20131051. https:\/\/doi.org\/10.1001\/jamapsychiatry.2020.1035 (2020).","journal-title":"JAMA Psychiatry"},{"key":"84897_CR67","doi-asserted-by":"publisher","first-page":"107740","DOI":"10.1016\/j.addbeh.2023.107740","volume":"144","author":"K Petrilli","year":"2023","unstructured":"Petrilli, K. et al. High potency cannabis use, mental health symptoms and cannabis dependence: triangulating the evidence. Addict. Behav. 144, 107740. https:\/\/doi.org\/10.1016\/j.addbeh.2023.107740 (2023).","journal-title":"Addict. Behav."},{"key":"84897_CR68","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/dar.13747","volume":"43","author":"D Dawson","year":"2024","unstructured":"Dawson, D., Stjepanovic, D., Lorenzetti, V., Hall, W. D. & Leung, J. How much cannabis is used in a joint in Australia? An experimental investigation into use by potency and frequency. Drug Alcohol Rev. 43, 226\u2013232. https:\/\/doi.org\/10.1111\/dar.13747 (2024).","journal-title":"Drug Alcohol Rev."},{"key":"84897_CR69","doi-asserted-by":"publisher","unstructured":"Leung, J., Stjepanovi\u0107, D., Dawson, D. & Hall, W. D. Do Cannabis users reduce their THC dosages when using more potent Cannabis products? A review. Front. Psychiatry. 12 https:\/\/doi.org\/10.3389\/fpsyt.2021.630602 (2021).","DOI":"10.3389\/fpsyt.2021.630602"},{"key":"84897_CR70","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1080\/16066359.2022.2049255","volume":"30","author":"WC Kerr","year":"2022","unstructured":"Kerr, W. C. & Ye, Y. Estimating usual grams per day of marijuana use from purchases. Addict. Res. Theory. 30, 360\u2013367. https:\/\/doi.org\/10.1080\/16066359.2022.2049255 (2022).","journal-title":"Addict. Res. Theory"},{"key":"84897_CR71","doi-asserted-by":"publisher","first-page":"102740","DOI":"10.1016\/j.drugpo.2020.102740","volume":"79","author":"JP Caulkins","year":"2020","unstructured":"Caulkins, J. P., Pardo, B. & Kilmer, B. Intensity of cannabis use: findings from three online surveys. Int. J. Drug Policy. 79, 102740. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102740 (2020).","journal-title":"Int. J. Drug Policy"},{"key":"84897_CR72","doi-asserted-by":"publisher","first-page":"10154","DOI":"10.1038\/s41598-018-28127-0","volume":"8","author":"A Suraev","year":"2018","unstructured":"Suraev, A. et al. Composition and use of cannabis extracts for childhood epilepsy in the Australian community. Sci. Rep. 8, 10154. https:\/\/doi.org\/10.1038\/s41598-018-28127-0 (2018).","journal-title":"Sci. Rep."},{"key":"84897_CR73","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1111\/bcp.14038","volume":"85","author":"SA Millar","year":"2019","unstructured":"Millar, S. A. et al. A systematic review of cannabidiol dosing in clinical populations. Br. J. Clin. Pharmacol. 85, 1888\u20131900. https:\/\/doi.org\/10.1111\/bcp.14038 (2019).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"84897_CR74","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1038\/s41386-020-0667-2","volume":"45","author":"E Chesney","year":"2020","unstructured":"Chesney, E. et al. Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials. Neuropsychopharmacology 45, 1799\u20131806. https:\/\/doi.org\/10.1038\/s41386-020-0667-2 (2020).","journal-title":"Neuropsychopharmacology"},{"key":"84897_CR75","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/cts.13425","volume":"16","author":"JC Arnold","year":"2023","unstructured":"Arnold, J. C., McCartney, D., Suraev, A. & McGregor, I. S. The safety and efficacy of low oral doses of cannabidiol: an evaluation of the evidence. Clin. Transl. Sci. 16, 10\u201330. https:\/\/doi.org\/10.1111\/cts.13425 (2023).","journal-title":"Clin. Transl. Sci."},{"key":"84897_CR76","doi-asserted-by":"publisher","unstructured":"Algar, J. L., Lawes, D. J., Carroll, A. J., Caldicott, D. & McLeod, M. D. Identification of three unexpected new psychoactive substances at an Australian drug checking service. Drug Test. Anal. n\/a, https:\/\/doi.org\/10.1002\/dta.3637 (2024).","DOI":"10.1002\/dta.3637"},{"key":"84897_CR77","unstructured":"Australian Capital Territory Government. CanTEST Health and Drug Checking Service https:\/\/www.health.act.gov.au\/about-our-health-system\/population-health\/pill-testing  (2024)."},{"key":"84897_CR78","unstructured":"ABC Canberra. in A new study led by CAN-ACT allows backyard cannabis growers in the ACT to send samples of their crops to the University of Sydney for testing. (ed abccanberra). (2023)."},{"key":"84897_CR79","unstructured":"ACT Government. Cannabis. https:\/\/www.act.gov.au\/cannabis\/home (2024)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84897-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84897-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84897-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T10:02:27Z","timestamp":1738663347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84897-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["84897"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-84897-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"assertion":[{"value":"24 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"IM has acted as a consultant to Kinoxis Therapeutics and has received honoraria from Althea and Janssen. He is an inventor on several patents relating to novel cannabinoid and non-cannabinoid therapeutics. His research is funded by the Lambert Initiative and the Australian National Health and Medical Research Council (NHMRC). IM and DM have received consultancy income from the Medicinal Cannabis Industry Association (MCIA) of Australia and provided expert testimony in medicolegal cases related to cannabis. Other authors report no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2649"}}